ADAPT PO: Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Tebipenem Compared to IV Ertapenem in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis

PIVOT PO: A Study of Oral Tebipenem Pivoxil Hydrobromide Compared to Intravenous Imipenem-Cilastatin in Participants With Complicated Urinary Tract Infection or Acute Pyelonephritis

VANQUISH: Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

AGILE (Early Phase Platform Trial for COVID-19)

AGILE (Early Phase Platform Trial for COVID-19)

A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea

SCYNERGIA: Study to Evaluate the Safety and Efficacy of the Coadministration of Ibrexafungerp (SCY-078) With Voriconazole in Patients With Invasive Pulmonary Aspergillosis (SCYNERGIA)

FURI: Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment

Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections

A Study to Evaluate Efficacy and Safety of GEPOTIDACIN in the Treatment of Uncomplicated Urinary Tract Infection

Comparative Study to Evaluate Efficacy and Safety of GEPOTIDACIN to NITROFURANTOIN in Treatment of Uncomplicated Urinary Tract Infection

CARES: Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris

MARIO: A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole